MedTrace Logo

24 Hour Use of the Wearable Artificial Kidney

NCT02280005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2017-07-18

No results posted yet for this study

Summary

This is a prospective, interventional study designed to provide preliminary data on the human use of the WAK. Up to 10 subjects currently receiving intermittent hemodialysis (HD) treatment three times per week for end-stage renal disease (ESRD) via an indwelling tunneled catheter will be studied.

Conditions

Interventions

DEVICE

WAK Treatment

Hemodialysis with WAK device.

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • Wearable Artificial Kidney Foundation

    collaborator UNKNOWN

  • Blood Purification Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Jonathan Himmelfarb, MD · University of Washington

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02280005 on ClinicalTrials.gov